Waldencast plc Overview
Pro stress-test →Waldencast plc is a global multi-brand beauty and wellness platform focused on developing, acquiring, accelerating, and scaling conscious and purpose-driven brands. The company operates through two segments: Obagi Medical and Milk Makeup, serving a global footprint across the US, Canada, Europe, Middle East, and Asia-Pacific.
Strategic Profile
Pro stress-test →Waldencast's asset-light, omnichannel model and early international expansion position it for strong premiumization, acquisition opportunities, and higher-than-expected long-term earnings growth. However, the company faces operational challenges, with H1 2025 net loss of $185.2M driven by goodwill impairments of $132.1M (Obagi) and $20.0M (Milk Makeup), and announced sale of Obagi Medical to Bridgepoint (June 1, 2026), representing a strategic restructuring.
Competitive Landscape
Pro stress-test →Waldencast offers medical-grade skincare (Obagi) addressing aging, pigmentation, and texture concerns, plus cosmetics including foundations, concealers, primers, and color products (Milk Makeup). The company competes in the premium skincare and color cosmetics segments against brands like Estée Lauder's portfolio, Unilever's premium brands, and direct-to-consumer beauty startups.
Industry Context
Waldencast plc operates in Prestige Beauty & Skincare.
Key facts
Founded: 2020 · Headquarters: London, UK · Employees: N/A · Revenue: $132.3M (H1 2025) · Market cap: $210M (as of mid-June 2026)